Sequential vs concurrent epirubicin and docetaxel as adjuvant chemotherapy for high-risk, node-negative, early breast cancer: an interim analysis of a randomised phase III study from the Hellenic Oncology Research Group
In: BRITISH JOURNAL OF CANCER, Jg. 117 (2017), Heft 2, S. 164-170
Online
serialPeriodical
Zugriff:
Titel: |
Sequential vs concurrent epirubicin and docetaxel as adjuvant chemotherapy for high-risk, node-negative, early breast cancer: an interim analysis of a randomised phase III study from the Hellenic Oncology Research Group
|
---|---|
Autor/in / Beteiligte Person: | Mavroudis, D. ; Saloustros, E. ; Boukovinas, I. ; Papakotoulas, P. ; Kakolyris, S. ; Ziras, N. ; Christophylakis, C. ; Kentepozidis, N. ; Fountzilas, G. ; Rigas, G. |
Link: | |
Zeitschrift: | BRITISH JOURNAL OF CANCER, Jg. 117 (2017), Heft 2, S. 164-170 |
Veröffentlichung: | 2017 |
Medientyp: | serialPeriodical |
ISSN: | 0007-0920 (print) |
Sonstiges: |
|